Atrial Lesions in a Pedigree With PRKAG2 Cardiomyopathy: Involvement of Disrupted AMP-Activated Protein Kinase Signaling.

Chen S, Lin Y, Zhu Y, Geng L, Cui C, Li Z, Liu H, Chen H, Ju W, Chen M

Open source

DOI
10.3389/fcvm.2022.840337
Published
2022
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2022.840337,
  title = {Atrial Lesions in a Pedigree With PRKAG2 Cardiomyopathy: Involvement of Disrupted AMP-Activated Protein Kinase Signaling.},
  author = {Chen S and Lin Y and Zhu Y and Geng L and Cui C and Li Z and Liu H and Chen H and Ju W and Chen M},
  year = {2022},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2022.840337},
  url = {https://doi.org/10.3389/fcvm.2022.840337}
}

RIS

TY  - JOUR
TI  - Atrial Lesions in a Pedigree With PRKAG2 Cardiomyopathy: Involvement of Disrupted AMP-Activated Protein Kinase Signaling.
AU  - Chen S
AU  - Lin Y
AU  - Zhu Y
AU  - Geng L
AU  - Cui C
AU  - Li Z
AU  - Liu H
AU  - Chen H
AU  - Ju W
AU  - Chen M
PY  - 2022
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2022.840337
UR  - https://doi.org/10.3389/fcvm.2022.840337
ER  - 

APA

S, C., Y, L., Y, Z., L, G., C, C., Z, L., H, L., H, C., W, J., & M, C. (2022). Atrial Lesions in a Pedigree With PRKAG2 Cardiomyopathy: Involvement of Disrupted AMP-Activated Protein Kinase Signaling.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2022.840337

Source records